Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of JAG2 mRNA | affects expression | 16483693
|
C015001 |
arsenite |
arsenite results in increased expression of JAG2 mRNA | increases expression | 18191166
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of JAG2 mRNA | decreases expression | 19150397
|
D002117 |
Calcitriol |
Calcitriol results in decreased expression of JAG2 mRNA | decreases expression | 16002434
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of JAG2 mRNA | decreases expression | 16404146
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of JAG2 mRNA | increases expression | 17606305
|
C025462 |
sulindac sulfide |
sulindac sulfide results in increased expression of JAG2 mRNA | increases expression | 16184548
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of JAG2 mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.82 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.17 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.90 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.32 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.56 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.56 | 14692618 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.83 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
3.13 | 18759972 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.61 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.76 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.77 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.80 | 15885639 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 16609825 17157402 19232924 18985861 18396377 15238991 18940202 17507914 18177632 18316065 17688650 18558336 18775368 20603192 19460635 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.18 | 20046352 17594078 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.54 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.08 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.04 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.42 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.42 | 18628466 17369602 16096432 16595493 15136595 18382427 19526202 15993339 15939500 17983394 16264153 16826403 18695136 11325840 17426702 15668708 15692762 16935488 15634643 18234424 16322301 15567936 16115903 15994142 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.19 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
2.25 | 16023760 18059187 17876044 16234567 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
3.51 | 12391285 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.26 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
5.10 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
5.10 | 6189445 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.68 | 17007740 17928571 17308081 16612575 16651473 17974986 15476868 16242529 16109756 15811867 17351982 15792986 16731534 17382496 17131338 16278810 16269455 16455267 17329180 17924179 18627295 16952015 17519947 16364871 15505089 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.01 | 16243910 17334414 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.88 | 20889678 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.78 | 20734317 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.05 | 17681005 11677210 16105132 17110522 16919318 15861022 17333356 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
2.62 | 15037631 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18802399 18259882 |
MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 9531541 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 16575769 8888407 17688650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
4.30 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
4.30 | 19641884 1733752 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.84 | 18602426 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.31 | 1851702 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
10.05 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
10.05 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.60 | 17359293 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.53 | 18037988 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.46 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.29 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.04 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.80 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.60 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.40 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.12 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
14.65 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
14.65 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
14.65 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.26 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.41 | 18558336 8888407 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.93 | 19069698 |
MESH:D005355 |
Fibrosis |
|
arsenite |
4.37 | 18296743 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.49 | 17150277 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.68 | 15692506 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.64 | 16495754 16144979 16244372 16244371 18006777 16707910 14766674 18674790 16879835 12587719 17875725 17888722 16330681 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.48 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.14 | 15692506 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.62 | 18501091 17606976 15147373 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.20 | 17688650 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.12 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.72 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.64 | 17937319 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.18 | 15369732 16775033 15699352 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.40 | 16707910 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.53 | 16085563 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.18 | 16294345 17596541 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
3.54 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.15 | 16439617 16595196 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
3.15 | 16842330 17085340 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.64 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
2.87 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.87 | 17418594 6189445 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.63 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.99 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.87 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.17 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.31 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.14 | 17638057 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.36 | 18765137 18803445 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.74 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.13 | 17415656 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.27 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.28 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.03 | 19429709 15857846 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.03 | 18259882 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
4.75 | 15738583 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.08 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.21 | 16889571 15640375 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.27 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.37 | 15555623 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.31 | 15930896 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.95 | 11578682 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.53 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.53 | 17638057 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.17 | 20603192 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
5.12 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.44 | 15754350 16289102 16644109 18247401 12479363 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.44 | 16888761 15897917 16868541 16729912 15749863 18437689 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.65 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.92 | 11422049 12752131 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.53 | 17922066 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.44 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.22 | 17710206 15625365 17203757 16767912 18313854 15675481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.52 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.13 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.89 | 11738929 16876388 1511512 15475178 3137016 17978042 11044598 14763951 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
3.05 | 15692506 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.87 | 17203757 15625365 16767912 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.32 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.96 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.92 | 12833885 |
MESH:D013576 |
Syndactyly |
marker/mechanism |
|
| 9531541 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.88 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.37 | 15669648 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.55 | 16010429 17909728 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.61 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.86 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
2.84 | 17653716 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.95 | 8888407 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
10.64 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
10.64 | 18645019 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.78 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.53 | 16364871 17334414 17638931 17678736 |